Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.4M
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
90.6M
-
Shares change
-
-1.92M
-
Total reported value, excl. options
-
$2.67B
-
Value change
-
-$53.9M
-
Put/Call ratio
-
0.08
-
Number of buys
-
91
-
Number of sells
-
-104
-
Price
-
$29.48
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock (ACHC) as of Q3 2020
244 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock as of Q3 2020.
Acadia Healthcare Company, Inc. - Common Stock (ACHC) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.6M shares
of 92.4M outstanding shares and own 98% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.4M shares), VANGUARD GROUP INC (7.5M shares), BlackRock Inc. (7.46M shares), DIMENSIONAL FUND ADVISORS LP (6.2M shares), P2 Capital Partners, LLC (5.58M shares), JPMORGAN CHASE & CO (3.58M shares), ABRAMS BISON INVESTMENTS, LLC (2.85M shares), STATE STREET CORP (2.15M shares), and Davide Leone & Partners Investment Co Ltd. (2.02M shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.